Cancer
Malignant Prostate Neoplasm
CI-CAN-00005927Explore in graph →
Top-level1,377 active trials24 approved drugs58 evidence items
- NCIt
- C7378
- ICD-10
- C61
- DOID
- 10283
- Other
- 2 more codes
Loading cancer entity…
Loading cancer entity…
Cancer
CI-CAN-00005927Explore in graph →
Clinical trials
5,981 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (730)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04340024 | Discovery of Biomarkers for Intrinsic Radiation Sensitivity in Cancer Patients | recruiting | — | 5,000 | National Cancer Centre, SingaporeOTHER | 1 | Jun 11, 2025 | clinicaltrials |
| NCT06546267 | Advanced Radiotherapy (ART) in Prostate Cancer (PROST-ART)(PROST-ART) | recruiting | — | 2,500 | IRCCS San RaffaeleOTHER | 1 | Jun 11, 2025 |
| NCT01342367 | Feasibility of Hormones and Radiation for Intermediate or High Risk Prostate Cancer | active not recruiting | N/A | 74 | University of ChicagoOTHER | 1 | Jun 10, 2025 | clinicaltrials |
| NCT02804815 | Add-Aspirin: A Trial Assessing the Effects of Aspirin on Disease Recurrence and Survival After Primary Therapy in Common Non Metastatic Solid Tumours | active not recruiting | Phase 3 | 11,000 | University College, LondonOTHER | 2 | Jun 10, 2025 | clinicaltrials |
| NCT05936736 | 24 Gy in One Fraction Urethral-sparing "HDR Like" SBRT for Prostate Cancer(PRO-FAST) | recruiting | N/A | 70 | IRCCS San RaffaeleOTHER | 1 | Jun 8, 2025 | clinicaltrials |
| NCT06215508 | Geriatric Assessment and Technology Evaluation in Prostate Cancer | recruiting | — | 120 | University of ChicagoOTHER | 1 | Jun 8, 2025 | clinicaltrials |
| NCT06815055 | State of Play of Physiotherapy in the Postoperative Management of Prostate Cancer : Prospective, Monocentric, National Survey, Aiming to Explore the Technics of Physiotherapy (PREduKiné)(PREduKiné) | not yet recruiting | — | 510 | Centre Hospitalier de RoubaixOTHER | 0 | Jun 5, 2025 | clinicaltrials |
| NCT07001709 | Determining the Effect of Abiraterone on the Metabolism of Oxycodone in Men With Prostate Cancer (the ENABLE Study)(ENABLE) | recruiting | Phase 4 | 29 | Deventer ZiekenhuisOTHER | 1 | Jun 3, 2025 | clinicaltrials |
| NCT03564275 | Proton Boost in Prostate Cancer | active not recruiting | N/A | 10 | University of CincinnatiOTHER | 1 | May 31, 2025 | clinicaltrials |
| NCT06355336 | Real World Prostate Cancer Registry(RWPCR) | recruiting | — | 1,000 | Cincinnati Cancer AdvisorsNETWORK | 1 | May 31, 2025 | clinicaltrials |
| NCT05805436 | Preop Laxatives in Robotic Urologic Surgery | recruiting | Phase 4 | 240 | Chad R. TracyOTHER | 1 | May 30, 2025 | clinicaltrials |
| NCT06049355 | EMBRACE: Exercising Together | recruiting | Phase 2 | 400 | OHSU Knight Cancer InstituteOTHER | 1 | May 29, 2025 | clinicaltrials |
| NCT01221168 | Epidemiologic and Genetic Study on Familial Prostate Cancer | recruiting | — | 10,000 | Centre de Recherche sur les Pathologies ProstatiquesOTHER | 1 | May 23, 2025 | clinicaltrials |
| NCT03392181 | PET/MRI for the Staging of Newly Diagnosed Prostate Cancer | active not recruiting | Early Phase 1 | 48 | Northwestern UniversityOTHER | 1 | May 23, 2025 | clinicaltrials |
| NCT06985004 | Predicting Operational Difficulties and Outcomes of RARP Based on Preoperative Assessment - Introducing the PIODO Questionnaire | active not recruiting | — | 288 | Pomeranian Medical University SzczecinOTHER | 1 | May 22, 2025 | clinicaltrials |
| NCT06383052 | A Phase 1/2 Study of 177Lu-NYM032 Injection in mCRPC | active not recruiting | Phase 1 / Phase 2 | 30 | Norroy Bioscience Co., LTDINDUSTRY | 1 | May 21, 2025 | clinicaltrials |
| NCT05443412 | Artificial Intelligence (AI)-Assisted Risk-based Prostate Cancer Detection | recruiting | — | 510 | Chinese University of Hong KongOTHER | 1 | May 20, 2025 | clinicaltrials |
| NCT06981377 | PRostate Cancer Plasma Integrative Multi-modal Evaluation(PRIME) | recruiting | — | 800 | Santa Chiara HospitalOTHER | 1 | May 20, 2025 | clinicaltrials |
| NCT06977906 | Improved Robotic-Assisted Radical Prostatectomy for Locally Advanced Prostate Cancer: Bladder Suspension and Preliminary Outcomes | recruiting | N/A | 300 | First Affiliated Hospital of Fujian Medical UniversityOTHER | 1 | May 18, 2025 | clinicaltrials |
| NCT06974539 | TULIP ReTrain Study(TULIP ReTrain) | not yet recruiting | N/A | 212 | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)OTHER | 1 | May 16, 2025 | clinicaltrials |
| NCT04848909 | Stereotactic Body Radiotherapy (SBRT) Post Prostatectomy(PLUTO-MPC) | active not recruiting | N/A | 30 | Sunnybrook Health Sciences CentreOTHER | 1 | May 15, 2025 | clinicaltrials |
| NCT06972628 | Treatment of Patients With Progressive mCRPC With 177Lu-PSMA-617 | recruiting | Phase 2 | 30 | Ebrahim S DelpassandOTHER | 1 | May 15, 2025 | clinicaltrials |
| NCT03874884 | 177Lu-PSMA-617 Therapy and Olaparib in Patients With Metastatic Castration Resistant Prostate Cancer(LuPARP) | active not recruiting | Phase 1 | 70 | Peter MacCallum Cancer Centre, AustraliaOTHER | 1 | May 14, 2025 | clinicaltrials |
| NCT06971211 | Radiotherapy Combined With Fluzopanib and Abiraterone Acetate Tablets (II) Treatment for mCRPC(PARTOM) | recruiting | Phase 2 | 40 | Jianbin BiOTHER | 1 | May 14, 2025 | clinicaltrials |
| NCT06139575 | Phase 1/2 Clinical Study of Lutetium Lu 177 JH020002 Injection in Patients With Advanced Prostate Cancer | recruiting | Phase 1 / Phase 2 | 90 | Bivision Pharmaceuticals, Inc.INDUSTRY | 1 | May 13, 2025 | clinicaltrials |
| NCT06966089 | ExosomeDx in MRI-negative Men With High PSA | not yet recruiting | N/A | 425 | Icahn School of Medicine at Mount SinaiOTHER | 1 | May 11, 2025 | clinicaltrials |
| NCT04186585 | Recommended Dose Estimation of BP-C2 | recruiting | Phase 1 | 8 | MeddocOTHER | 1 | May 9, 2025 | clinicaltrials |
| NCT05582876 | Multicenter Assessment of Clinical Utility PET / MR With the Use of the Radiotracer 68Ga-PSMA-11 in Therapy Planning Personalized in Patients With Prostate Cancer(PROSPETMR2021) | recruiting | N/A | 366 | Medical University of BialystokOTHER | 1 | May 8, 2025 | clinicaltrials |
| NCT03344835 | Hong Kong Prostate Cancer Study Group Database | recruiting | — | 15,000 | Chinese University of Hong KongOTHER | 1 | May 6, 2025 | clinicaltrials |
| NCT03703778 | Real-life Evaluation of the Effect of ADT in Prostate Cancer Patients in Asia (READT Asia Study)(READT) | active not recruiting | — | 300 | Chinese University of Hong KongOTHER | 1 | May 6, 2025 | clinicaltrials |
| NCT03893929 | The Investigation of New Biological Markers for Prostate Cancer Diagnosis and Management in Chinese Population | recruiting | — | 5,000 | Chinese University of Hong KongOTHER | 1 | May 6, 2025 | clinicaltrials |
| NCT03914391 | To Identify Potential New Urine Markers for the Screening of Prostate Cancer | recruiting | — | 10,000 | Chinese University of Hong KongOTHER | 1 | May 6, 2025 | clinicaltrials |
| NCT05179824 | Tempus Priority Study: A Pan-tumor Observational Study | active not recruiting | — | 1,000 | Tempus AIINDUSTRY | 1 | May 6, 2025 | clinicaltrials |
| NCT05761093 | Patient and Physician Benefit/ Risk Preferences for Treatment of mPC in Hong Kong: a Discrete Choice Experiment | recruiting | — | 306 | Chinese University of Hong KongOTHER | 1 | May 6, 2025 | clinicaltrials |
| NCT06163924 | The Effect of Multidisciplinary Care Approach on CV Risk Modification in CaP Patients Receiving ADT | recruiting | — | 130 | Chinese University of Hong KongOTHER | 1 | May 6, 2025 | clinicaltrials |
| NCT06262633 | A Multi-centre Trial on Targeted Microwave Ablation (TMA) for Localized Prostate Cancer | recruiting | N/A | 103 | Chinese University of Hong KongOTHER | 1 | May 6, 2025 | clinicaltrials |
| NCT06360523 | To Evaluate an MRI-based Optimized Prostate Cancer Diagnostic Pathway Powered by Artificial Intelligence | recruiting | N/A | 368 | Chinese University of Hong KongOTHER | 1 | May 6, 2025 | clinicaltrials |
| NCT04253262 | A Study of Copanlisib Combined With Rucaparib in Patients With Metastatic Castration-resistant Prostate Cancer | active not recruiting | Phase 1 / Phase 2 | 13 | Brown UniversityOTHER | 1 | May 4, 2025 | clinicaltrials |
| NCT03998657 | Continued Access of Focal MR-Guided Focused Ultrasound for Localized Intermediate Risk Prostate Lesions | active not recruiting | N/A | 14 | InSightecINDUSTRY | 1 | May 1, 2025 | clinicaltrials |
| NCT04503265 | A Trial of AMXI-5001 for Treatment in Patients With Advanced Malignancies | recruiting | Phase 1 / Phase 2 | 122 | AtlasMedx, IncorporatedINDUSTRY | 1 | May 1, 2025 | clinicaltrials |
| NCT05715502 | Focal Salvage Brachytherapy Study (FocaSaBra)(FocaSaBra) | recruiting | N/A | 100 | The Greater Poland Cancer CentreOTHER | 1 | Apr 30, 2025 | clinicaltrials |
| NCT06950216 | IONM During Radical Prostatectomy | not yet recruiting | N/A | 40 | The Fourth Affiliated Hospital of Zhejiang University School of MedicineOTHER | 0 | Apr 30, 2025 | clinicaltrials |
| NCT06950307 | Hypofractionation for Prostate Cancer in Africa: A Feasibility Study(HypoAfrica) | active not recruiting | — | 182 | Muhimbili University of Health and Allied SciencesOTHER | 3 | Apr 30, 2025 | clinicaltrials |
| NCT03689699 | Nivolumab and BMS-986253 for Hormone-Sensitive Prostate Cancer (MAGIC-8) | active not recruiting | Phase 1 / Phase 2 | 59 | Mark SteinOTHER | 1 | Apr 29, 2025 | clinicaltrials |
| NCT03857477 | The BARCODE 1 Study (Full Study): The Use of Genetic Profiling to Guide Prostate Cancer Targeted Screening.(BARCODE1) | active not recruiting | — | 4,700 | Institute of Cancer Research, United KingdomOTHER | 1 | Apr 29, 2025 | clinicaltrials |
| NCT06946771 | Exploring the Correlation Between MRI Image Characteristics and Diagnosis, Pathology and Prognosis in Patients With Prostate Lesions | recruiting | — | 500 | Zhen LiOTHER | 1 | Apr 27, 2025 | clinicaltrials |
| NCT06945315 | SAFE Nerve Sparing Guided by Micro-ultrasound (MUS) | recruiting | Phase 3 | 196 | Icahn School of Medicine at Mount SinaiOTHER | 1 | Apr 25, 2025 | clinicaltrials |
| NCT06702995 | Study of XNW5004 Tablet in Combination With Enzalutamide in Subjects With Metastatic Castration-Resistant Prostate Cancer | recruiting | Phase 1 / Phase 2 | 307 | Evopoint Biosciences Inc.INDUSTRY | 1 | Apr 20, 2025 | clinicaltrials |
| NCT06935487 | European Multicenter Validation of PCaVision: A Head-to-Head Diagnostic Accuracy Study Comparing Multiparametric Transrectal Ultrasound to MRI for Clinically Significant Prostate Cancer Detection(PCaVISTA) | active not recruiting | N/A | 806 | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)OTHER | 6 | Apr 20, 2025 | clinicaltrials |
| NCT06458855 | Nerve Grafting Technique to Restore Erectile Function Post Radical Prostatectomy(PRP-NR) | active not recruiting | N/A | 10 | Sir Mortimer B. Davis - Jewish General HospitalOTHER | 1 | Apr 18, 2025 | clinicaltrials |
Data updated 23 days agoSource updated Jun 11, 2025source: clinicaltrials